Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients

AiCuris AG, a German biotech company, is currently recruiting for their clinical trial on Pritelivir. Pritelivir is a highly anticipated new treatment for resistant Herpes Simplex Virus infections that cannotContinueContinue reading “Pritelivir: Clinical Trial Recruiting for resistant Herpes Simplex Virus Infection in immune compromised Patients”

Call for Herpes Advocates: Rally for a cure with us!

Want to rally for a cure with us? Why isn’t there a herpes cure or even a diagnostic test that works? Why have there been no treatment improvements in 40ContinueContinue reading “Call for Herpes Advocates: Rally for a cure with us!”

National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget

Herpes Cure Advocacy confirms a national strategy and strategic plan for Herpes Simplex Virus Types 1 and 2 in the approved House FY 2022 budget. On page 245, the HouseContinueContinue reading “National Strategy for Herpes: A DHHS Strategic Plan in House FY 2022 Budget”

Current Herpes Cure Research at Excision BioTherapeutics

Excision Bio has illustrated the possibility in developing a curative gene therapy using CRISPR in treating both active and latent HSV infection in the body. The company has stated thatContinueContinue reading “Current Herpes Cure Research at Excision BioTherapeutics”